View allAll Photos Tagged brainstorming

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

020

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:05 AM

THE NEXT ENDANGERED SPECIES: THE DOCTOR

Lost in the conversation of the digital health revolution is the focus on humans that often drive transformation in healthcare and that’s the medical doctor. We’ve seen doctors increasingly demoralized, depressed, and under pressure to meet mounting administrative loads while maintaining impeccable, patient-rated “healthgrades” online. The epidemic of burnout now affects almost two-thirds of America’s physicians according to a recent Medscape study. They’re frustrated by the payment systems and being pushed out by large health systems that imagine others doing their work and stripping them of authority. They spend less and less time with patients, and there’s giddy talk about how soon robots—already active in surgery and radiology—will do it all. Do we really want to imagine a world without doctors?

 

Dr. Toby Cosgrove, Former President and CEO, Cleveland Clinic

Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

Teen producers brainstorm about their shoot

029

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:00 PM

THE SMARTPHONE-ACID DOPAMINE-DRIVEN FEEDBACK LOOPS

Why you’re an addict and you don’t even know it: A 21st century dilemma.

 

Tristan Harris, Co-founder, Time Well Spent

 

Photograph by Stuart Isett/Fortune

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

BANKING ON CHANGE

A decade after the financial crisis, Bank of America’s profits are at record highs, yet persistently low interest rates and rising recession fears pose risks. Meanwhile, online challengers and new technologies such as A.I. have pushed it to raise the bar on modern banking. A conversation with the head of one of America’s top banks about leading in uncertain times.

Brian Moynihan, Chairman and CEO, Bank of America

Moderator: Shawn Tully, Senior Editor-at-Large, FORTUNE

 

photo by Rebecca Greenfield for Fortune

023

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:40 AM

HOW AI WILL CHANGE MEDICINE

The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.

 

Adrian Aoun, CEO and Founder, Forward

Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health

Julie Sweet, Chief Executive Officer, North America, Accenture

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

029

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:00 PM

THE SMARTPHONE-ACID DOPAMINE-DRIVEN FEEDBACK LOOPS

Why you’re an addict and you don’t even know it: A 21st century dilemma.

 

Tristan Harris, Co-founder, Time Well Spent

 

Photograph by Stuart Isett/Fortune

Matèria Original @ Laboratori Teatral Patates amb Suc

Fotografies: Pol Marzà

038

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:55 PM

FOLLOW THE GAZE: WHAT WEBCAM EYE-TRACKING CAN TEACH US

Our eyes and the way we look at our screens have the potential to unlock crucial data that can transform the way we are treated. A demonstration of one of the most eye-opening new diagnostic technologies coming down the pike.

 

Dr. Alexandra Papoutsaki, Assistant Professor in Computer Science, Pomona College

 

Photograph by Stuart Isett/Fortune

014

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

7:00 PM–9:00 PM

DINNER AND FEATURED INTERVIEW

Hosted by IBM Watson Health

 

WELCOME

Deborah DiSanzo, General Manager, IBM Watson Health

 

THE SECRET TO TONY ROBBINS’ SUCCESS

He’s the go-to life and business strategist for high-octane CEOs, athletes, celebrities, and politicians. And, his empire of seminars, books, audio, video, and life training programs has empowered more than 50 million people from 100 countries who may not be lucky enough to have him on speed dial. Tony Robbins insists he can teach anyone to be confident, but where did the CEO Whisperer’s own strength come from? Fresh from another wildly popular “Unleash the Power Within” event, here’s Robbins as you’ve never seen him before. Joining us for an intimate interview in which he shares his own difficult personal upbringing, Robbins reveals how he went from homeless to household name—and how he can teach anyone else to believe in themselves.

 

Tony Robbins, Life and Business Strategist; Author, Unshakeable, Money: Master the Game

Interviewer: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

Mobile payments and blockchain have challenged the status quo of cross-border money transfers, putting pressure on traditional players. Yet money can be stubbornly hard to move, and the old systems hard to improve upon. A conversation between the leader of Zelle, a bank-owned mobile payments app that has eclipsed Venmo in transactions, and the CEO of 168-year-old Western Union, a leader in cross-border, cross-currency money movement and payments.

Lou Anne Alexander, Group President, Payment Solutions, Early Warning Services

Hikmet Ersek, President and CEO, Western Union

Moderator: Robert Hackett, Co-chair, Brainstorm Finance; Co-founding Editor, The Ledger; Senior Writer, FORTUNE

 

Photography by Rebecca Greenfield/Fortune

011

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:10 PM

PRECISION MEDICINE: WHERE IT’S WORKING AND WHY

The tools of molecular medicine, today, are homing in on human disease with a precision that could only be imagined a decade ago. New advances in big data, genomic medicine, and supercomputing are paving the way for targeted, personalized treatment. What has been the clinical impact so far—and what can we really expect in the five years to come? A deep dive with three individuals who are putting these tools into practice.

 

Kathy Giusti, Founder, Multiple Myeloma Research Foundation (MMRF); Faculty Co-chair, Kraft Precision Medicine Accelerator, Harvard Business School

Othman Laraki, Co-Founder and CEO, Color

Dr. Vijay Pande, General Partner, Andreessen Horowitz

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

Matèria Original @ Laboratori Teatral Patates amb Suc

Fotografies: Pol Marzà

Board a 65′ x 29′ open bridge deck catamaran, inspired by traditional Polynesian double-canoe and enjoy a two hour sail from Gurney’s Yacht Club, out and back, through the harbor and sound.

026

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

11:10 AM

A MOTHER FIGHTS BACK: USING BIG DATA AND GENOMICS TO SILENCE HER SON’S KILLER

Theresa Beech’s 13-year-old son Daniel died nearly two years ago from osteosarcoma. Daniel’s killer: a pediatric bone cancer whose treatment—and survival rates—haven’t changed in 30 years. But the time for change is now. Driven by the hope that she can spare other families this same pain and loss, Theresa — a space engineer by day — has collected the genetic codes from more than 100 young patients whose parents donated the data. What she has discovered offers hope for progress at last. The unbelievable story of one woman’s race to cure a terrible cancer.

 

Theresa Beech, President, Because of Daniel

 

Photograph by Stuart Isett/Fortune

This is a brainstorm for another current project I am researching: Surrealism.

Creative thinking and brainstorming day

Uploaded with the Flock Browser

029

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:00 PM

THE SMARTPHONE-ACID DOPAMINE-DRIVEN FEEDBACK LOOPS

Why you’re an addict and you don’t even know it: A 21st century dilemma.

 

Tristan Harris, Co-founder, Time Well Spent

 

Photograph by Stuart Isett/Fortune

003

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:20 PM

U.S. HEALTH CARE: AT THE CROSSROADS

A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.

 

Mark Bertolini, Chairman and CEO, Aetna Inc.

Interviewer: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

017

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

7:45 AM

CONCURRENT BREAKFAST SOLUTION SESSIONS

THE END OF HEALTH CARE PRIVACY… AND IS IT A GOOD THING?

Someone forgot to tell consumers to be careful. Over the past several years, people everywhere have zealously shared their intimate health data with products and services like 23AndMe, FitBit, and the Apple Watch—eager to be guinea pigs in the grand Big Data Experiment of Human Health. But when it comes to the broader medical universe, a matrix of rules and proprietary interests have made discovery from this deep data reservoir restrictive and challenging. Some, likewise, blame the frustrating lack of interoperability in health systems on a misreading of privacy protections—as well as on the unwillingness of private companies to play in the same data sandbox. How do we harness our limitless health-related data while still protecting individual privacy? And here’s a provocative question to start us off: Is privacy all it’s cracked up to be?

 

Anu Acharya, CEO, Mapmygenome

Dr. Kevin Ban, Chief Medical Officer, athenahealth

Colin Hill, Co-Founder, Chairman and CEO, GNS Healthcare

Chrissa McFarlane, Chief Executive Officer, Patientory

Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute

Hal Wolf, President and CEO, Healthcare Information and Management Systems Society

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

009

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

4:40 PM

THE MOTHER OF INVENTION

Necessity isn’t the mother of invention, creativity is. But where do you find the special spark that can help transform a product from merely a “cool” piece of tech to a must-have that can change lives for the better? And, in an age when billions of dollars are being pumped into digital health and medical technology ventures, how can stakeholders identify the most promising innovations? A conversation with some of the most creative minds in the health space.

 

James Park, Co-founder and CEO, Fitbit

Dr. Martine Rothblatt, Chairman and Chief Executive Officer, United Therapeutics Corp.

Moderator: Sue Siegel, Chief Innovation Officer, GE; Chief Executive Officer, GE Ventures

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

035

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

PATIENT TRIALS WE CAN ACTUALLY LEARN FROM

Hosted by City of Hope

The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

 

Matt de Silva, Co-Founder, CEO and Director, Notable Labs

Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator

Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

024

 

Fortune Brainstorm Design 2018

Wednesday, March 7th, 2018

Singapore

 

13:00 - 14:45

 

LUNCH DISCUSSIONS

 

Choose 1 of 4

 

DISRUPTION X DESIGN

Design is a potent weapon for startups as well as giant global firms. Too often, however, new ventures—and the investors who fund them—make the mistake of assuming that new technology and more data is the solution to every problem. The most successful startups prevail because of their superb user experience, aesthetics, and ability to forecast and create solutions for challenges yet unknown. Entrepreneurs and experts share insights on the integral role disruptive design is playing in an increasingly competitive marketplace.

 

Robbie Antonio, Chief Executive Officer, Revolution Precrafted

Charles Hayes, Partner and Executive Managing Director, Asia, IDEO

Yuichiro Hori, Chief Executive Officer and Founder, Stellar Works

Kohei Nishiyama, Co-founder, Elephant Design Holdings; Founder and CEO, CUUSOO System

Moderator: Clay Chandler, Brainstorm Design

 

Photograph by Stefen Chow/Fortune

041

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:05 PM

TAKE TWO TERABYTES AND CALL ME IN THE MORNING: DATA’S GROWING ROLE IN THE MEDICAL TOOL BOX

At the core of precision medicine is precision: the critical need to hit, square on, a moving target in a body chock full of moving targets. To keep the aim sound, we need more than a steady hand, we need data. Smart data, and lots of it. That imperative has driven much of the innovation—and investment—in the current digital health transformation. Entrepreneurs and corporate leaders are now championing the role of big data in everything from drug development to predictive analytics in cancer diagnosis to hospital systems management—and putting billions of dollars behind these efforts. Do the numbers add up, or is the promise of big data yet another false medical miracle?

  

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

Dr. Kyu Rhee, Vice President and Chief Health Officer, IBM Corporation

Dr. Mona Siddiqui, Chief Data Officer, U.S. Dept. of Health and Human Services

 

Photograph by Stuart Isett/Fortune

016

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

7:45 AM

CONCURRENT BREAKFAST SOLUTION SESSIONS

WHY YOU SHOULD SLEEP THROUGH THIS SESSION

The data is real. A good night of sleep can have enormous benefits for our health, well-being, and productivity. Yet, despite the science, many of us continue to forgo the shut-eye we need. Part of the reason is a profound misunderstanding of productivity and where it comes from: While today’s digital world seems to demand that we’re always connected, there’s a smarter, healthier way to get more done. We explore what individuals and companies can do to create a well-rested workplace and what impact that can have on decision making, problem solving, and the bottom line. Can we really change the culture of ALWAYS ON? Rest assured, we can.

 

Liat Ben-Zur, Senior Vice-President, Connected Digital Platforms and Propositions, Royal Philips

Roger Ekirch, Professor of History, Virginia Tech

Dr. Lauren Hale, Professor, Family, Population, and Preventive Medicine; Core Faculty, Program in Public Health, Stony Brook University School of Medicine

Cheri Mah, Research Fellow, Human Performance Center, UC San Francisco

Moderator: David Cloud, CEO, National Sleep Foundation

 

Photograph by Stuart Isett/Fortune

008

Monday, September 24, 2018

Fortune Brainstorm Reinvent

Chicago, IL, USA

 

3:25 PM

REINVENTION AND THE BOARD

Boards comprised of the right mix of leaders can be much more than a practical and financial advisory body. What are the common obstacles that boards face and how can boards reshape their role to best support growth and innovation for the companies they serve?

 

John Chambers, Founder and CEO, JC2 Ventures

Wan Ling Martello, Executive Vice President and Chief Executive Officer Zone Asia, Oceania and sub-Saharan Africa (AOA), Nestlé

Ann Ziegler, Director, Hanesbrands, Wolters Kluwer, Groupon; Former Senior Vice President and CFO, CDW

Moderator: Clifton Leaf, Editor-in-Chief, Fortune

 

Photograph by Stuart Isett/Fortune

Rockharz, 2014, Flugplatz Ballenstedt

LIVING IN TOMORROW’S MATERIAL WORLD

As technology continues to advance, so will everything from access to credit to the way we pay for purchases. A look at what impact this evolving payments industry will have on customers and businesses of all sizes.

Patrick Gauthier, Vice President, Amazon Pay

Margaret Keane, Chief Executive Officer, Synchrony

Moderator: Jeff Roberts, Co-chair, Brainstorm Finance; Editor, The Ledger; Senior Writer, Law & Policy Reporter, FORTUNE

 

Photography by Rebecca Greenfield/Fortune

023

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:40 AM

HOW AI WILL CHANGE MEDICINE

The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.

 

Adrian Aoun, CEO and Founder, Forward

Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health

Julie Sweet, Chief Executive Officer, North America, Accenture

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

First brainstorm focused on violence

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

004

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:45 PM

MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

 

Deborah DiSanzo, General Manager, IBM Watson Health

Amy Powell, President, Paramount Television and Digital Entertainment

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

BANKING ON CHANGE

A decade after the financial crisis, Bank of America’s profits are at record highs, yet persistently low interest rates and rising recession fears pose risks. Meanwhile, online challengers and new technologies such as A.I. have pushed it to raise the bar on modern banking. A conversation with the head of one of America’s top banks about leading in uncertain times.

Brian Moynihan, Chairman and CEO, Bank of America

Moderator: Shawn Tully, Senior Editor-at-Large, FORTUNE

 

photo by Rebecca Greenfield for Fortune

IDHA students brainstorm in collaborative group activity.

1 2 ••• 68 69 71 73 74 ••• 79 80